Jacqueline Ramirez
Family Medicine · Miami, FLNPI 1285854125
Payments from drug & device makers
Across 434 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$733
- Novo Nordisk$699
- Lilly USA, LLC$656
- Boehringer Ingelheim$563
- AbbVie$520
- plus $4K from 24 others
What the payments were for
- Food & beverage$8,452100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $1,620 |
| GSK | 42 | $733 |
| Novo Nordisk | 37 | $699 |
| Lilly USA, LLC | 40 | $656 |
| Boehringer Ingelheim | 31 | $563 |
| AbbVie(2 entities) | 30 | $520 |
| Johnson & Johnson | 25 | $484 |
| Pfizer | 19 | $400 |
| Merck | 15 | $288 |
| Novartis | 16 | $284 |
| Amneal Pharmaceuticals LLC | 16 | $273 |
| Sanofi-aventis U.S. LLC | 13 | $245 |
| Kowa Pharmaceuticals America, Inc. | 13 | $236 |
| Amarin Pharma, Inc. | 8 | $155 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $147 |
| Scilex Pharmaceuticals Inc. | 8 | $146 |
| Amgen | 7 | $135 |
| Corcept Therapeutics | 6 | $123 |
| Phathom Pharmaceuticals, Inc. | 6 | $118 |
| Abbott | 5 | $108 |
| Optinose US, Inc. | 6 | $101 |
| Bayer | 4 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $70 |
| Ironwood Pharmaceuticals, Inc | 3 | $68 |
| Idorsia Pharmaceuticals US Inc | 4 | $64 |
| Exact Sciences | 2 | $51 |
| Evoke Pharma, Inc. | 2 | $42 |
| Eisai Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,458 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $19,304 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,038 |
| Gabapentin | 32 | $540 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $398 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $288 |
| Metoprolol Succinate | 13 | $181 |
| Fluticasone Propionate | 11 | $159 |
| Losartan Potassium | 23 | $152 |
| Pantoprazole Sodium | 24 | $113 |
| Atorvastatin Calcium | 23 | $108 |
| Ibuprofen | 11 | $92 |
| Rosuvastatin Calcium | 16 | $71 |
| Levothyroxine Sodium | 22 | $67 |
| Tamsulosin Hcl | 14 | $59 |
| Alprazolam | 14 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $400 | $19,30411 claims |
| GSKTrelegy Ellipta | $733 | $7,03811 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $273 | $6722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Miami
- Keila HooverMiami$33.7M
- Jorge CasoMiami$22.6M
- David WyattMiami$13.7M
- Jose CardenasMiami$13.2M
- Lazaro GarciaMiami$10.3M
- Ibrahim Menendez PerezMiami$8.9M
- Aniel Navarro MarinMiami$7.3M
- Gilberto SecoMiami$6.8M
- Ramon LeonMiami$6.3M
- Eddy CapoteMiami$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.